The significant and growing global prevalence of diabetes continues to challenge people
with diabetes (PwD), healthcare providers, and payers. While maintaining near-normal …

Background The possible advantage of hybrid closed-loop therapy (ie, artificial pancreas)
over sensor-augmented pump therapy in very young children with type 1 diabetes is …

Aims To explore parents' experiences of using a hybrid closed-loop system (CamAPS FX)
when caring for a very young child (aged 1–7 years) with type 1 diabetes. Methods …

Aims To explore parents' experiences of using remote monitoring technology when caring
for a very young child with type 1 diabetes during a clinical trial. Methods Interviews were …

Objectives We explored parents' views about healthcare professionals having remote
access to their young child's insulin and glucose data during a clinical trial to inform use of …

Introduction. Parents of children living with type 1 diabetes (T1D) often report short and/or
poor quality sleep. The development of closed‐loop systems promises to transform the …

A significant metabolic illness known as diabetes mellitus is characterized by a lack of
insulin or the pancreas failure to produce enough insulin. The blood glucose levels rise as a …

Abstract Type 1 diabetes (T1D) is a lifelong condition with serious acute and chronic
complications. Current therapies are inadequate to achieve desired metabolic control and to …

A true artificial endocrine pancreas (AEP), or a closed-loop automated insulin delivery
system, or, more precisely, a glucose-controlled automated insulin delivery system, has …